[1] Oh J, Reiser J, Mundel P. Dynamic (re)organization of the podocyte actin cytoskeleton in the nephrotic syndrome. Pediatr Nephrol. 2004;19(2):130-137.[2] 王彦江,谢席胜,王宝福,等. 足细胞巢蛋白与糖尿病肾病蛋白尿发生机制的研究新进展[J].现代中西医结合杂志,2012,21(19): 2158-2161.[3] 刘巍,段惠军,张悦,等.中间丝蛋白Nestin在不同病程糖尿病大鼠肾组织中的表达[J].中国组织化学与细胞化学杂志,2011,20(4): 301-305.[4] Reiniger N,Lau K,McCalla D,et al.Deletion of the receptor for advanced glycation end products reduces glomerulosclerosis and preserves renal function in the diabetic OVE26 mouse. Diabetes.2010;59(8):2043-2054. [5] 尤莉,陈靖,苏蔚,等.巢蛋白在足突广泛融合的肾小球中表达下调及与蛋白尿程度的相关性[J].中华肾脏病杂志,2008,24(6): 405-410.[6] 管娜,丁洁,张敬京,等.肾病综合征患儿肾小球中nephrin、podocin、α-actinin及WT1的表达[J]. 肾脏病与透析肾移植杂志, 2002,11(3):205-210.[7] 苏蔚,陈靖,杨海春,等.足细胞中巢蛋白的表达及其相互作用分子的研究[J].中华肾脏病杂志,2006,22(7):406-410.[8] Geske P, Huber TB, Sellin L, et al. Homodimerization and heterodimerization of the glomerular podocyte proteins,nephrin and NEPH1. J Am Soc Nephrol.2003;14:918-926[9] Chen J, Boyle S, Zhao M, et al. Differential expression of the intermediate filemant protein nestin during renal development and its localization in adult podocytes. J Am Soc Nephrol. 2006;17:1283.[10] 张悦,魏民,王谦,等.阿霉素复制大鼠微小病变肾病模型的研究[J].北京中医药大学学报,2002,25(2):16-18.[11] 刘晓雅,任雅丽,管娜,等.阿霉素大鼠肾病模型足细胞线粒体体视学分析[J].中国体视学与图像分析,2014,18(4):365-373. [12] Abo-Salem OM. The protective effect of aminoguanidine on doxo- rubicin-induced nephropathy in rats. J Biochem Mol Toxicol. 2012,26(1):1-9.[13] 张勇,张蓓,宁华英,等.单次尾静脉注射法阿霉素大鼠肾病模型的建立[J].中国实验动物学报,2013,10(1):1-4.[14] Grimbert P, Audard V, Remy P, et al.Recent approaches to the pathogensis of minimal-change nephrotic syndrome. Nephrol Dial Transplant. 2003;18:245-248.[15] Dettmar AK, Binder E, Greiner FR, et al. Protection of human podocytes from shiga toxin 2-induced phosphorylation of mitogen- activated protein kinases and apoptosis by human serum amyloid P component. Infect Immun. 2014;82(5): 1872-1879.[16] 叶晓华,杨青,林瑞霞,等. 吗替麦考酚酯治疗小儿频复发肾病综合征的疗效观察[J].温州医学院学报, 2014,44(7):528-532.[17] Banerjee S,Pahari A,Sengupta J,et al.Outcome of severe steroid-dependent nephrotic syndrome treated with mycophenolate mofetil. Pediatr Nephrol. 2013;28(1):93-97.[18] Afzal K, Bagga A, Menon S, et al. Treatment with mycophenolate mofetil and prednisolone for steroid-dependent nephrotic syndrome. Pediatr Nephrol. 2007;22(12):2059-2065.[19] 贾立山,李晓忠.小儿微小病变肾病综合征免疫发病机制研究进展[J].临床肾脏病杂志,2013,12(11):488-491.[20] Wang L,Li Q, Wang LJ,et al. Level of Th17 cell and CIM(+) ; CD25 (+); Foxp3 (+); regulatory T cell in peripheral blood mononuclear cells of primary nephrotic syndrome in children. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2010;26:783-786.[21] 颜思璐,宁岑.小儿原发性肾病综合征复发危险因素的相关性分析[J].广西医学,2013,35(6):753-754.[22] Le Berre L, Bruneau S, Naulet J,et al. Induction of T regulatory cells attenuates idiopathic nephrotie syndrome. J Am Soc Nephrol. 2009;20:57-67.[23] 马晓红,何立群.不同剂量阿霉素致大鼠局灶节段硬化肾病模型的建立比较[J].中国比较医学杂志,2013,21(1):37-42.[24] Patrie KM. Interaction of Two Aetin-binding Proteins, synaptopodin and alpha-Actinin-4, with the Tight Junction Protein MAGI-1. J Biol Chem. 2002;277(33):180-183. |